Pros and cons of sharing Zika discoveries straight from the lab

The quick spread and potentially devastating public health risks of the Zika virus in North and South America have researchers, drug companies and government officials scrambling to land on a plan to fight back.

But considering the magnitude of these endeavors, the efforts are so many and so widespread that data sharing might not be as efficient as necessary to develop a cure or vaccine as soon as possible.

So, according to the New York Times, one research team at the University of Wisconsin in Madison is giving away its Zika information for free online. The data is available for other scientists and physicians to build upon the existing research, for faster and cheaper advancements.

Of course, this also means that the researchers forgo the prestige and some of the peer-reviewed legitimacy that comes with being published in a journal.

Check out the New York Times to see how the researchers use monkeys to conduct their research along with the reaction from the rest of the scientific community. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.